Lasmiditan succinate
CAS No. 439239-92-6
Lasmiditan succinate ( —— )
Catalog No. M21647 CAS No. 439239-92-6
Lasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 221 | Get Quote |
|
10MG | 333 | Get Quote |
|
25MG | 599 | Get Quote |
|
50MG | 898 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLasmiditan succinate
-
NoteResearch use only not for human use.
-
Brief DescriptionLasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
-
DescriptionLasmiditan succinate is a 5-ht (1F) receptor agonist acting on the central nervous system(Ki value of 2.21 nM).
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
Recptor5-HT
-
Research AreaNeurological Disease
-
IndicationMigraine
Chemical Information
-
CAS Number439239-92-6
-
Formula Weight872.81
-
Molecular FormulaC19H18F3N3O2·0.5(C4H6O4)
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)CCC(O)=O.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1.CN1CCC(CC1)C(=O)c1cccc(NC(=O)c2c(F)cc(F)cc2F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Capi M de Andrés Fernando Lionetto L et al. Lasmiditan for the treatment of migraine[J]. Expert Opinion on Investigational Drugs 2017 26(2):227-234.
molnova catalog
related products
-
JNJ-5234801
JNJ-5234801 is an atypical anxiolytic targeting 5-HT2 receptor, has demonstrated oral activity in animal models of anxiety.
-
Triflupromazine hydr...
Triflupromazine hydrochloride is an antipsychotic medication, which are Dopamine D1/D2 receptor antagonists.
-
Quetiapin
Quetiapine is indicated for the treatment of schizophrenia as well as for the treatment of acute manic episodes associated with bipolar I disorder.